Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | MK-1308A |
Trade Name | |
Synonyms | Pembrolizumab/Quavonlimab|MK1308A|MK 1308A |
Drug Descriptions |
Limited information is currently available on MK-1308A, a coformulation of Pembrolizumab and Quavonlimab (Apr 2023). |
DrugClasses | CTLA4 Antibody 31 Immune Checkpoint Inhibitor 149 PD-L1/PD-1 antibody 121 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Lenvatinib + MK-1308A | Lenvatinib MK-1308A | 0 | 5 |
MK-1308A | MK-1308A | 0 | 3 |
MK-1308A + MK-4830 | MK-1308A MK-4830 | 0 | 1 |